Stock NAMS NEWAMSTERDAM PHARMA COMPANY N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts NewAmsterdam Pharma Company N.V. Nasdaq

Equities

NAMS

NL00150012L7

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
20.99 USD +0.57% Intraday chart for NewAmsterdam Pharma Company N.V. +4.95% +87.91%
Jul. 08 NewAmsterdam Pharma Completes Enrollment for Phase 3 Trial of Potential Cardiovascular Disease Treatment MT
Jul. 08 NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib plus Ezetimibe in Patients with HeFH and/or ASCVD or ASCVD Risk Factors CI

Transcripts

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Transcript : NewAmsterdam Pharma Company N.V. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 10:40 AM
Transcript : NewAmsterdam Pharma Company N.V. - Special Call
Transcript : NewAmsterdam Pharma Company N.V. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 04:35 PM
Transcript : NewAmsterdam Pharma Company N.V. Presents at Leerink Partners Global Biopharma Conference 2024, Mar-11-2024 04:00 PM
Transcript : NewAmsterdam Pharma Company N.V. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 02:10 PM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NAMS Stock
  4. NAMS Stock
  5. News NewAmsterdam Pharma Company N.V.
  6. Transcripts